--- title: Buy Nexavar (Sorafenib) 200mg Tabs Online description: Nexavar (Sorafenib) 200mg Tabs is a trusted treatment for advanced kidney, liver, and thyroid cancers. Order from our secure pharmacy for reliable delivery. type: product language: en url: https://medsforsale.net/buy-nexavar-online-en availability: in_stock price_min: 224.99 price_max: 827.99 currency: USD offers: - name: 200mg x 30 tabs price: 224.99 - name: 200mg x 60 tabs price: 425.99 - name: 200mg x 90 tabs price: 629.99 - name: 200mg x 120 tabs price: 827.99 --- # Buy Nexavar (Sorafenib) 200mg Tabs Online Nexavar, containing the active ingredient Sorafenib, is a highly effective kinase inhibitor originally developed by Bayer. This medication is primarily used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and certain types of thyroid cancer by blocking the growth of cancer cells. It is intended for adults requiring targeted therapy for specific oncology needs. Our online pharmacy provides a secure and efficient way to purchase Nexavar in 200mg tabs with guaranteed quality. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **200mg** | 30 tabs | **$224.99** | $7.50 | In Stock | | **200mg** | 60 tabs | **$425.99** | $7.10 | In Stock | | **200mg** | 90 tabs | **$629.99** | $7.00 | In Stock | | **200mg** | 120 tabs | **$827.99** | $6.90 | In Stock | [Buy Now](https://medsforsale.net/buy-nexavar-online-en) ## Introduction Nexavar (generic name Sorafenib) is an oral multikinase inhibitor prescribed primarily for the treatment of advanced hepatocellular carcinoma (HCC) and unresectable renal cell carcinoma (RCC). The medication is supplied as 200 mg tablets and belongs to the class of targeted anticancer agents that interrupt tumor-cell signaling pathways. It is also approved for differentiated thyroid carcinoma that is refractory to radioactive iodine. In addition to these FDA- and EMA-approved uses, clinicians sometimes explore Sorafenib for other malignancies under investigational protocols. ## What is Nexavar? Nexivar is a brand-name formulation of the active pharmaceutical ingredient sorafenib. Sorafenib was originally developed by Bayer Pharma and later licensed to Onyx Pharmaceuticals (acquired by Bayer). The product received its first regulatory approval in 2005 for advanced renal cell carcinoma and subsequently for hepatocellular carcinoma and radioactive-iodine-refractory thyroid cancer. The drug is marketed under brand names such as **Nexavar** and **Sorafenib** in various regions, with the generic tablet available in 200 mg strengths. ## How Nexavar Works Sorafenib inhibits multiple intracellular kinases, including RAF kinases (CRAF, BRAF), vascular endothelial growth factor receptors (VEGFR-1, -2, -3), platelet-derived growth factor receptor-β (PDGFR-β), FLT-3, and c-KIT. By blocking these enzymes, sorafenib reduces tumor angiogenesis (formation of new blood vessels) and directly impairs tumor-cell proliferation and survival. The inhibition is dose-dependent; steady-state plasma concentrations are typically reached after 7 days of daily dosing. Sorafenib is metabolized mainly by CYP3A4 and UGT1A9, with an elimination half-life of approximately 25-48 hours, supporting once-daily administration. ## Conditions Treated with Nexavar - **Advanced Hepatocellular Carcinoma (HCC)** - Sorafenib improves overall survival by targeting angiogenic pathways that are highly active in liver tumors. - **Unresectable Renal Cell Carcinoma (RCC)** - The drug delays disease progression by inhibiting VEGF-driven vascular growth in kidney cancer. - **Radioactive Iodine-Refractory Differentiated Thyroid Cancer** - Sorafenib provides disease control when tumors no longer respond to standard iodine therapy. In each of these indications, clinical trials (e.g., SHARP for HCC and TARGET for RCC) demonstrated statistically significant extensions of median overall survival compared with placebo, establishing sorafenib as a cornerstone of systemic therapy. ## Off-Label and Investigational Uses of Nexavar - **Primary Brain Tumors (e.g., Glioblastoma multiforme)** - Small phase II studies suggest modest activity when combined with radiotherapy, but data remain preliminary. - **Advanced Melanoma** - Sorafenib has been investigated in combination regimens; however, newer immune-checkpoint inhibitors have largely superseded it. - **Metastatic Breast Cancer** - Early-stage trials explored sorafenib with chemotherapy, showing variable response rates. These applications are **not approved** by the FDA or EMA. Any off-label use should occur only under the direct supervision of a qualified oncologist and within an ethical, protocol-driven framework. ## Is Nexavar the Right Medication for You? Sorafenib is indicated for adult patients with confirmed advanced HCC, unresectable RCC, or iodine-refractory differentiated thyroid cancer who have measurable disease and adequate organ function. It is especially appropriate when surgical or locoregional options are exhausted. Contraindications include severe hepatic impairment (Child-Pugh C), uncontrolled hypertension, and known hypersensitivity to sorafenib or its excipients. Caution is advised in patients with a history of cardiac ischemia, QT-prolongation, or significant wound-healing complications. ## Risks, Side Effects, and Interactions ### Common - Hand-foot skin reaction (palmar-plantar erythrodysesthesia) - Diarrhea - Hypertension - Fatigue - Rash ### Rare - Alopecia (hair loss) - Dysgeusia (altered taste) - Stomatitis (mouth sores) - Elevated liver enzymes (ALT/AST) ### Serious - Cardiac ischemia or myocardial infarction - Severe hemorrhage, including gastrointestinal bleeding - QT-interval prolongation leading to arrhythmia - Hepatic failure or severe transaminase elevation - Severe skin reactions such as Stevens-Johnson syndrome #### Drug-Drug Interactions - **CYP3A4 inhibitors** (e.g., ketoconazole, clarithromycin) increase sorafenib exposure → dose reduction may be required. - **CYP3A4 inducers** (e.g., rifampin, carbamazepine) lower sorafenib plasma levels → may reduce efficacy. - **Anticoagulants** (warfarin, direct oral anticoagulants) raise bleeding risk; monitor coagulation parameters closely. - **Antihypertensives** - sorafenib can exacerbate hypertension; blood pressure should be controlled before and during therapy. #### Food and Lifestyle Interactions - High-fat meals may modestly increase sorafenib absorption; consistent administration with or without food is recommended. - Grapefruit juice strongly inhibits CYP3A4 and should be avoided. - Alcohol consumption can worsen hepatic toxicity; limit intake. ## Use: Dosing, Missed Dose, Overdose - **Standard dosing** for adult patients is 400 mg (two 200 mg tablets) taken orally twice daily, approximately 12 hours apart. - Dose adjustments are made based on toxicity: reduce to 400 mg once daily, then to 200 mg once daily, and discontinue if severe adverse events persist. - **Missed dose** - If the scheduled time is within 4 hours, take the missed tablet; otherwise skip it and resume the regular schedule. Do not double-dose. - **Overdose** - Symptoms may include severe diarrhea, hypertension, and cardiac arrhythmia. Seek immediate medical attention; activated charcoal may be considered if ingestion was recent. - **Practical precautions** - Take tablets with a full glass of water; avoid crushing or splitting. Do not operate heavy machinery if dizziness or fatigue occurs. Alcohol should be limited. ## FAQ - **Can I travel internationally with Nexavar?** Sorafenib tablets are stable at room temperature for at least 24 months. Carry them in their original labeled container, keep them away from extreme heat, and bring a copy of the prescription or a physician’s letter for customs if required. - **Does Nexavar interact with herbal supplements?** St. John’s wort and other CYP3A4-inducing herbs may lower sorafenib levels, potentially reducing efficacy. Discuss any supplement use with your oncology team. - **What do the tablets look like?** The 200 mg tablets are typically white, film-coated, and bear the imprint “200 S” on one side and a manufacturer logo on the other. - **Are there differences between brand-name Nexavar and generic sorafenib?** Both contain the same active ingredient and are required to meet identical bioequivalence standards. Inactive excipients may vary slightly, which can affect tolerability for a minority of patients. - **How is Nexavar disposed of after the treatment course?** Unused tablets should be placed in a sealed container and returned to a pharmacy with a medication-take-back program or disposed of according to local hazardous-waste regulations. - **Can sorafenib affect laboratory test results?** Yes. It may cause transient elevations in liver enzymes and bilirubin, which should be distinguished from disease progression. Routine monitoring is essential. - **Is dose timing critical for effectiveness?** Maintaining a consistent 12-hour interval maximizes steady-state concentrations and reduces fluctuation-related side effects. - **Will Nexavar cause weight gain or loss?** Weight loss is more common, often due to decreased appetite, diarrhea, or cancer-related cachexia. Nutritional counseling may be beneficial. - **Can I take sorafenib while on dialysis?** Sorafenib is partially cleared hepatically; renal impairment does not markedly alter exposure, but patients should be monitored for heightened toxicity. - **Is there a need for pre-treatment testing?** Baseline assessments include liver function tests, blood pressure measurement, ECG (for QT assessment), and a comprehensive metabolic panel. These establish safe starting parameters. ## Glossary **Multikinase Inhibitor** : A drug that blocks several kinase enzymes involved in tumor growth and blood-vessel formation, thereby hindering cancer progression. **Palmar-Plantar Erythrodysesthesia** : A painful skin reaction affecting the palms and soles, commonly called “hand-foot syndrome,” characterized by redness, swelling, and sometimes peeling. **CYP3A4** : An enzyme in the liver that metabolizes many medications; inhibitors increase drug levels while inducers lower them. **QT-Interval Prolongation** : An extension of the heart’s electrical repolarization phase on an ECG, which can predispose to serious arrhythmias. ## Buying Nexavar from [our online pharmacy](https://medsforsale.net/buy-nexavar-online-en) Patients who encounter limited access to sorafenib through conventional channels can obtain the medication from **[our online pharmacy](https://medsforsale.net/buy-nexavar-online-en)**. Our service sources Nexavar directly from licensed, verified manufacturers, allowing us to offer the product at prices close to the manufacturer’s cost. Each batch undergoes stringent quality-control testing to ensure potency and purity, providing confidence that the medication meets international pharmaceutical standards. Delivery is discreet and reliable: express shipping typically arrives within 7 days, while standard airmail takes about 3 weeks, both packaged in unmarked envelopes to protect privacy. Because we operate as a pharmacy-broker service, we collaborate with overseas licensed pharmacies, expanding availability for patients in regions where sorafenib is scarce or prohibitively expensive. Our platform respects patient confidentiality, using secure encryption for all transactions and offering anonymous packaging options for those who prefer extra discretion. By choosing **[our online pharmacy](https://medsforsale.net/buy-nexavar-online-en)**, patients gain a cost-effective, trustworthy pathway to the treatment they need, without compromising safety or privacy. ## Disclaimer The information presented about **Nexavar** is intended for general educational purposes and does not substitute for professional medical advice. Treatment decisions-including those involving off-label uses-must be made under the supervision of a qualified healthcare provider. Readers are presumed to be responsible adults capable of making informed health choices. [our online pharmacy](https://medsforsale.net/buy-nexavar-online-en) supplies **Nexavar** to individuals who may face limited access through traditional pharmacies or insurance programs and who seek affordable generic alternatives. Always consult a qualified clinician before initiating, altering, or discontinuing any medication.